Literature DB >> 33773413

Impaired performance of SARS-CoV-2 antigen-detecting rapid diagnostic tests at elevated and low temperatures.

Verena Haage1, Edmilson Ferreira de Oliveira-Filho1, Andres Moreira-Soto1, Arne Kühne1, Carlo Fischer1, Jilian A Sacks2, Victor Max Corman3, Marcel A Müller3, Christian Drosten3, Jan Felix Drexler4.   

Abstract

Antigen-detecting rapid diagnostic tests (Ag-RDTs) can complement molecular diagnostics for COVID-19. The recommended temperature for storage of SARS-CoV-2 Ag-RDTs ranges between 2-30 °C. In the global South, mean temperatures can exceed 30 °C. In the global North, Ag-RDTs are often used in external testing facilities at low ambient temperatures. We assessed analytical sensitivity and specificity of eleven commercially-available SARS-CoV-2 Ag-RDTs using different storage and operational temperatures, including short- or long-term storage and operation at recommended temperatures or at either 2-4 °C or at 37 °C. The limits of detection of SARS-CoV-2 Ag-RDTs under recommended conditions ranged from 1.0×106- 5.5×107 genome copies/mL of infectious SARS-CoV-2 cell culture supernatant. Despite long-term storage at recommended conditions, 10 min pre-incubation of Ag-RDTs and testing at 37 °C resulted in about ten-fold reduced sensitivity for five out of 11 SARS-CoV-2 Ag-RDTs, including both Ag-RDTs currently listed for emergency use by the World Health Organization. After 3 weeks of storage at 37 °C, eight of the 11 SARS-CoV-2 Ag-RDTs exhibited about ten-fold reduced sensitivity. Specificity of SARS-CoV-2 Ag-RDTs using cell culture supernatant from common respiratory viruses was not affected by storage and testing at 37 °C, whereas false-positive results occurred at outside temperatures of 2-4 °C for two out of six tested Ag-RDTs, again including an Ag-RDT recommended by the WHO. In summary, elevated temperatures impair sensitivity, whereas low temperatures impair specificity of SARS-CoV-2 Ag-RDTs. Consequences may include false-negative test results at clinically relevant virus concentrations compatible with transmission and false-positive results entailing unwarranted quarantine assignments. Storage and operation of SARS-CoV-2 Ag-RDTs at recommended conditions is essential for successful usage during the pandemic.
Copyright © 2021 The Author(s). Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Rapid antigen test; SARS-CoV-2; Sensitivity; Specificity; Temperature stability; Tropics; Winter

Year:  2021        PMID: 33773413      PMCID: PMC7962993          DOI: 10.1016/j.jcv.2021.104796

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  12 in total

Review 1.  Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.

Authors:  Jacqueline Dinnes; Pawana Sharma; Sarah Berhane; Susanna S van Wyk; Nicholas Nyaaba; Julie Domen; Melissa Taylor; Jane Cunningham; Clare Davenport; Sabine Dittrich; Devy Emperador; Lotty Hooft; Mariska Mg Leeflang; Matthew Df McInnes; René Spijker; Jan Y Verbakel; Yemisi Takwoingi; Sian Taylor-Phillips; Ann Van den Bruel; Jonathan J Deeks
Journal:  Cochrane Database Syst Rev       Date:  2022-07-22

Review 2.  Rapid Antigen Assays for SARS-CoV-2: Promise and Peril.

Authors:  Thao T Truong; Jennifer Dien Bard; Susan M Butler-Wu
Journal:  Clin Lab Med       Date:  2022-03-04       Impact factor: 2.172

3.  An olfactory self-test effectively screens for COVID-19.

Authors:  Kobi Snitz; Danielle Honigstein; Reut Weissgross; Aharon Ravia; Eva Mishor; Ofer Perl; Shiri Karagach; Abebe Medhanie; Nir Harel; Sagit Shushan; Yehudah Roth; Behzad Iravani; Artin Arshamian; Gernot Ernst; Masako Okamoto; Cindy Poo; Niccolò Bonacchi; Zachary Mainen; Erminio Monteleone; Caterina Dinnella; Sara Spinelli; Franklin Mariño-Sánchez; Camille Ferdenzi; Monique Smeets; Kazushige Touhara; Moustafa Bensafi; Thomas Hummel; Johan N Lundström; Noam Sobel
Journal:  Commun Med (Lond)       Date:  2022-04-05

4.  Clinical Accuracy of Instrument-Read SARS-CoV-2 Antigen Rapid Diagnostic Tests (Ag-IRRDTs).

Authors:  Ali Umit Keskin; Pinar Ciragil; Aynur Eren Topkaya
Journal:  Int J Microbiol       Date:  2022-05-09

Review 5.  Performance Evaluation of Lateral Flow Assays for Coronavirus Disease-19 Serology.

Authors:  Lucy Ochola; Paul Ogongo; Samuel Mungai; Jesse Gitaka; Sara Suliman
Journal:  Clin Lab Med       Date:  2021-11-03       Impact factor: 1.935

6.  Performance Evaluation of the STANDARDTM Q COVID-19 and PanbioTM COVID-19 Antigen Tests in Detecting SARS-CoV-2 during High Transmission Period in Mozambique.

Authors:  Nádia Sitoe; Júlia Sambo; Neuza Nguenha; Jorfelia Chilaule; Imelda Chelene; Osvaldo Loquiha; Chishamiso Mudenyanga; Sofia Viegas; Jane Cunningham; Ilesh Jani
Journal:  Diagnostics (Basel)       Date:  2022-02-12

7.  Rapid comparative evaluation of SARS-CoV-2 rapid point-of-care antigen tests.

Authors:  Anna Denzler; Max L Jacobs; Victoria Witte; Paul Schnitzler; Claudia M Denkinger; Michael Knop
Journal:  Infection       Date:  2022-04-09       Impact factor: 7.455

8.  Development, Analytical, and Clinical Evaluation of Rapid Immunochromatographic Antigen Test for SARS-CoV-2 Variants Detection.

Authors:  Jidapa Szekely; Jenureeyah Mongkolprasert; Nitikorn Jeayodae; Chadarat Senorit; Panuttha Chaimuti; Piyawut Swangphon; Natthaphon Nanakorn; Teerapat Nualnoi; Paweena Wongwitwichot; Theerakamol Pengsakul
Journal:  Diagnostics (Basel)       Date:  2022-02-02

9.  Comparing the diagnostic accuracy of point-of-care lateral flow antigen testing for SARS-CoV-2 with RT-PCR in primary care (REAP-2).

Authors:  Werner Leber; Oliver Lammel; Andrea Siebenhofer; Monika Redlberger-Fritz; Jasmina Panovska-Griffiths; Thomas Czypionka
Journal:  EClinicalMedicine       Date:  2021-07-13

10.  Accuracy of novel antigen rapid diagnostics for SARS-CoV-2: A living systematic review and meta-analysis.

Authors:  Lukas E Brümmer; Stephan Katzenschlager; Mary Gaeddert; Christian Erdmann; Stephani Schmitz; Marc Bota; Maurizio Grilli; Jan Larmann; Markus A Weigand; Nira R Pollock; Aurélien Macé; Sergio Carmona; Stefano Ongarello; Jilian A Sacks; Claudia M Denkinger
Journal:  PLoS Med       Date:  2021-08-12       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.